The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Synaptic Pharmaceutical Corporation

Synaptic Pharmaceutical Corporation
Nasdaq: SNAP
Change
symbol:
     
 PROFILE
Synaptic Pharmaceutical wants to make sure its signals cross just right. The biotech firm is developing a process to discover and clone human receptor genes associated with specific disorders. By developing drugs designed to work with certain receptors (which receive cell-to-cell signals within the human body), the company hopes to create treatments that are more effective and have fewer side effects than traditional drugs. It focuses on several disorders, including depression and other central nervous system conditions, obesity, diabetes, and incontinence. The company has collaborative agreements with Germany's Grunenthal and Kissei Pharmaceutical.

 COMPETITION
Elan Corporation, plc (ELN)
Interneuron Pharmaceuticals, Inc. (IPIC)
Neurogen Corporation (NRGN)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 3.80
1-Yr. Sales Growth: 100.0%
Employees: 97
Revenue per employee: $39,175.26

 KEY PEOPLE
• Kathleen P. Mullinix
    CEO
• Robert L. Spence
    CFO

 CONTACT INFO
215 College Rd.
Paramus, NJ 07652
US
Phone: 201-261-1331
Fax: 201-261-0623
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001